New: NCI-funded clinical trial search
Mednet Logo

Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?

This question is part of our collaboration with ASTRO to highlight impactful data from the 2026 Multidisciplinary Radiopharmaceutical Symposium. This question is inspired by the Plenary Session Presentation "Clinical Challenges in Radiopharmaceutical Therapy" by Dr. Ana P. Kiess
3 Answers
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center
Answered on

In this situation, it is helpful to review the eligibility and exclusion criteria from the VISION protocol directly. These can be found at NCT03511664 (Sartor et al., PMID 34161051). Many of these patients have been heavily pretreated, including prior taxane therapy, so my main concern is that they have adequate baseline organ function. The requirements in this regard to be eligible for the study were:

  1. Bone marrow:
    • White blood cell (WBC) count >= 2.5 x 10^9/L (2.5 x 10^9/L is equivalent to 2.5 x 10^3/μL and 2.5 x K/μL and 2.5 x 10^3/cumm and 2500/μL) Or absolute neutrophil count (ANC) >= 1.5 x 10^9/L (1.5 x 10^9/L is equivalent to 1.5 x 10^3/μL and 1.5 x K/μL and 1.5 x 10^3/cumm and 1500/μL)
    • Platelets >= 100 x 10^9/L (100 x 10^9/L is equiv...

Join for free or sign in to see the full answer

Mednet Member
Radiation Oncology · Orlando Health UF Health Cancer Center Health Central Hospital
Answered on

I completely agree with Dr. @Dr. First Last's response. Dr. Kendra Harris taught me not to mess with the platelets, so I watch these closely. The Grade 5 events in the VISION trial were bleeding-related.

Not strict exclusion criteria but food for thought:

PS is important as patients should be able to do IADLs without assistance 2-3 days after administering the dose. Some of these men are quite old with mobility issues from disease or other medical conditions and rely on others to help them toilet. I’ve withheld treatment in this situation before.

Anecdotally from speaking with colleagues and n=1 personal experience, men with severe baseline LUTS likely aren’t eliminating drugs as fast as we would like, and I have had and heard of delayed prof...

Join for free or sign in to see the full answer

Mednet Member
Radiation Oncology · Seton Cancer Institute
Answered on

There are guidelines from EANM/SNMMI (Kratochwil et al., PMID 37246997) that do a good job IMO of discussing relative contraindications and are available for free from PMC. I personally use the following as absolute contraindications in community practice:

  • GFR <30
  • ECOG 3+
  • Active infection
  • Inability to comply with release requirements (i.e., severe psych comorbidity, dementia, etc)

Join for free or sign in to see the full answer